Paul R. Kileny, PhD, professor of Otolaryngology and director of Audiology and Electrophysiology at the University of Michigan, talks with Douglas Beck, AuD, about the area of intraoperative neurophysiological monitoring, shares some “war stories” from the operating room, and provides information about his new book, “The Audiologist’s Handbook of Intraoperative Neurophysiological Monitoring.”
Read More
“In 2017, Health Canada required that the patient medication information for mefloquine be updated to warn that in some people, dizziness, vertigo, tinnitus, and loss of balance may become permanent,” said Dr Remington Nevin, executive director of The Quinism Foundation.
Read More
With a better understanding of cortical brain changes associated with hearing loss, the potential to develop objective brain-based tools (ie, biomarkers) increases. These tools may help clinicians determine when a patient should receive intervention, what kind of intervention or rehabilitation would be ideal, and may offer the ability to monitor how well a chosen intervention or rehabilitation method is working. Prominent researchers Anu Sharma and Hannah Glick explain why.
Read More
There has been great interest in using speech-evoked cortical auditory evoked potentials (CAEP) as an objective hearing aid validation measure, because CAEPs allow us to assess the audibility of speech sounds at the highest (cortical) levels. Here is a review by Sridhar Krishnamurti and Larry Wise, as well as results from a study they conducted that suggests there is clinical value of CAEPs for assessing cortical changes from amplification, as well as using this data in audiology services to demonstrate patient benefit.
Read More
With these results in hand, the next step could be a treatment study based on vagus nerve stimulation—a therapy being pioneered by Vanneste and his colleagues at the Texas Biomedical Device Center at UT Dallas.
Read More
As with any branch of auditory science, research on CAPD continues to be pursued in many different areas. However, there is robust scientific evidence pertaining to the clinical existence, diagnosis, and treatment of CAPD. This short article provides a literature review for what might be viewed as six key tenets related to CAPD.
Read More
The reason for this finding could be that children with cochlear implants are older when they are first exposed to spoken language. Those with normal hearing learn aspects of language, such as the rhythm and melody of their mother tongue, from birth and even in the womb.
Read More
Starkey Hearing Technologies—an Eden Prairie, Minn-based hearing technology company—is launching a new line of hearing aids based on the company’s research in virtual reality, advanced neuroscience, and audiology and signal processing.
Read More
Exploration of domains related to the emotional experiences of the patient and family will act to sensitize our clientele to the topic of emotion, and possibly address underlying motivations for their visit. At a minimum, the evidence suggests that conversations about the emotional impact of hearing loss will provide a better understanding of the patient’s and family’s disability experience, foster a stronger therapeutic alliance, and likely lead to more positive practice outcomes, such as greater treatment adherence, more open and honest communication with patients, and greater patient satisfaction.
Read More
Central auditory processing disorder (CAPD) is a complex and evolving subject, but remains a solid diagnostic entity. While there is some variance in diagnostic criteria across US and European professional association guidelines, this simply reflects the need for additional research with participants with confirmed CAPD. A considerable body of research exists demonstrating the efficiency of individual central auditory tests and central auditory test batteries based on performance of individuals with confirmed CANS lesions, including such lesions in children. Authors Gail Chermak, PhD, Frank Musiek, PhD, and Jeffrey Weihing, PhD, provide information that will assist clinicians in making informed, evidence-based clinical decisions about CAPD.
Read More
David Owen, a well-known staff writer for The New Yorker, investigated some of the newest innovations in hearing aid technology to help treat his own hearing loss and tinnitus in an April 3 article in the magazine. In “High Tech Hope for the Hard of Hearing,” Owen details his experience being tested and fitted for a pair of Muse hearing aids at Starkey Hearing Technologies in Eden Prairie, Minnesota.
Read More
David Owen, a well-known staff writer for The New Yorker, investigated some of the newest innovations in hearing aid technology to help treat his own hearing loss and tinnitus in an April 3 article in the magazine. In “High Tech Hope for the Hard of Hearing,” Owen details his experience being tested and fitted for a pair of Muse hearing aids at Starkey Hearing Technologies in Eden Prairie, Minnesota.
Read More
Study compares the effective bandwidth and maximum gain before feedback of the Earlens device—a light-driven (as opposed to acoustically driven) hearing aid system—to six receiver-in-the-canal (RIC) hearing aids in similar conditions.
Read More
This review of clinical studies from three leading hearing aid research centers shows a consistent trend for the Signia primax features to significantly reduce listening effort. Moreover, research from one site revealed that speech recognition performance for hearing-impaired listeners (pure-tone average 35-60 dB) using the primax Narrow Directionality algorithm was equal to that of normal-hearing individuals for the same speech-in-noise task.
Read More
In his November blog, Hearing Review Editor Karl E. Strom discusses how, as learning technology advances, we should expect to see more interactive, video game-based approaches to aural rehabilitation (AR).
Read More